|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Boarding issue in a commercial flight for patients with cavitary pulmonary tuberculosis: A case report显示文摘BACKGROUND Several studies have demonstrated that airborne transmission of Mycobacterium tuberculosis bacteria from patients with active pulmonary tuberculosis(TB) to other passengers or crew members can occur during long flights. As such, non-infectious TB patients are usually allowed to undertake air travel after taking the appropriate anti-TB drugs. However, the global guidelines for air travel for patients with TB are inconsistent and insufficiently detailed with respect to cavitary pulmonary TB(CPTB).CASE SUMMARY Here, we report a case in which a patient with multiple CPTB was permitted air travel, following negative sputum acid-fast bacilli smear tests after administration of proper anti-TB medication. The patient’s culture results were pending.CONCLUSION This case revealed that more specific guidelines regulating air travel for patients with CPTB are necessary. | Woori Jo Chuiyong Pak Yangjin Jegal Kwang Won Seo | 2020 | World Journal of Clinical Cases2020，8，3： | 2 |
| 2 | Anticancer Activity of Marine Sponge Hyrtios sp. Extract in Human Colorectal Carcinoma RKO Cells with Different p53 Status显示文摘 | Hyun Kyung Lim Woori Bae Hyi-Seung Lee Joohee Jung Shun-Fa Yang | 2014 | BioMed Research International2014，，： | 1 |
| 3 | Dietary folate, one‐carbon metabolism‐related genes, and gastric cancer risk in Korea显示文摘 | Woori Kim Hae Dong Woo Jeonghee Lee Il Ju Choi Young Woo Kim Joohon Sung Jeongseon Kim | 2016 | Mol. Nutr. Food Res2016，，2： | 1 |
| 4 | Dislocation after total hip arthroplasty 显示文摘 | WooRY MorreyBF | 1982 | J Bone JointSurgAm1982，64，： | 1 |
| 5 | 不牺牲EMI的高效解决方案SuperFETⅡMOSFET显示文摘在智能手机和平板设备集成功能和不断减小的尺寸驱动下,过去几年中锂离子电池的能量密度显著提高。移动设备和电池技术的进步引导电池充电器设计人员将焦点放在改进电源转换效率、功率密度、工作温度、充电时间和输出功率及先进的功率器件、电路拓扑和控制方法上。半导体供应商任开发先进技术,实现高效率和高功率密度方面扮演着重要角色。 | Wonsuk Choi Woori Bae KyoungDeok Kim | 2016 | 中国电子商情2016，，4： | 0 |
| 6 | Long-term, in vivo therapeutic effects of a single dose of miR-145 micelles for atherosclerosis显示文摘Atherosclerosis is a chronic inflammatory disease that is characterized by the build-up of lipid-rich plaques in the arterial walls. The standard treatment for patients with atherosclerosis is statin therapy aimed to lower serum lipid levels. Despite its widespread use, many patients taking statins continue to experience acute events. Thus, to develop improved and alternative therapies, we previously reported on microRNA-145 (miR-145 micelles) and its ability to inhibit atherosclerosis by targeting vascular smooth muscle cells (VSMCs). Importantly, one dose of miR-145 micelles significantly abrogated disease progression when evaluated two weeks post-administration. Thus, in this study, to evaluate how long the sustained effects of miR-145 micelles can be maintained and towards identifying a dosing regimen that is practical for patients with chronic disease, the therapeutic effects of a single dose of miR-145 micelles were evaluated for up to two months in vivo. After one and two months post-treatment, miR-145 micelles were found to reduce plaque size and overall lesion area compared to all other controls including statins without causing adverse effects. Furthermore, a single dose of miR-145 micelle treatment inhibited VSMC transdifferentiation into pathogenic macrophage-like and osteogenic cells in plaques. Together, our data shows the long-term efficacy and sustained effects of miR-145 micelles that is amenable using a dosing frequency relevant to chronic disease patients. | Deborah D.Chin Neil Patel Woori Lee Sonali Kanaya Jackson Cook Eun Ji Chung | 2023 | Bioactive Materials2023，，9： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员